Search Results

You are looking at 141 - 150 of 496 items for :

  • "adjuvant chemotherapy" x
  • Refine by Access: All x
Clear All
Full access

Al B. Benson III, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Lucille A. Leong, Edward Lin, Michael G. Martin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Deborah A. Freedman-Cass, and Kristina M. Gregory

some patients with disease at lower risk of local recurrence (eg, proximal rectal cancer staged as T3,N0,M0, characterized by clear margins and favorable prognostic features) may be adequately treated with surgery and adjuvant chemotherapy. 38 , 109

Full access

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ernest U. Conrad III, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane III, Henry Koon, Joel Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Richard J. O'Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, and Jillian Scavone

Postoperative doxorubicin-based chemotherapy was associated with improved RFS in male patients and those older than 40 years, although female patients and those 40 years or younger who received adjuvant chemotherapy had marginally worse OS. However, RFS and OS

Full access

Al B. Benson III, Michael I. D’Angelica, Thomas A. Abrams, Chandrakanth Are, P. Mark Bloomston, Daniel T. Chang, Bryan M. Clary, Anne M. Covey, William D. Ensminger, Renuka Iyer, R. Kate Kelley, David Linehan, Mokenge P. Malafa, Steven G. Meranze, James O. Park, Timothy Pawlik, James A. Posey, Courtney Scaife, Tracey Schefter, Elin R. Sigurdson, G. Gary Tian, Jean-Nicolas Vauthey, Alan P. Venook, Yun Yen, Andrew X. Zhu, Karin G. Hoffmann, Nicole R. McMillian, and Hema Sundar

gemcitabine chemotherapy as options for adjuvant treatment. See “Adjuvant Chemotherapy and Chemoradiation for Biliary Tract Cancers,” page 1172. Management of Unresectable or Metastatic Disease Preoperative evaluation and a biopsy to confirm the

Full access

Rodger J. Winn

. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women . Ann Intern Med 2003 ; 138 : 90 – 97 . 12 Bloom BJ de Pourourville N Chhatre S . Breast cancer treatment in clinical practice compared to

Full access

Gregory P. Kalemkerian

thoracic surgery community, the primary additions to the literature have been retrospective reviews of institutional or registry data. That said, both Schneider et al. and the NCCN Guidelines Panel for SCLC agree that surgery followed by adjuvant

Full access

Steven M. Grunberg

effect of a consensus statement on the practice of physicians . N Engl J Med 1989 ; 321 : 1306 – 1311 . 26 Drug Utilization Review Team in Oncology . Antiemetic prescription in Italian breast cancer patients submitted to adjuvant

Full access

Robert J. Downey and Lee M. Krug

. Ann Thorac Surg 1992 ; 54 : 498 – 501 . 12 Coolen L Van den Eeckhout A Deneffe G . Surgical treatment of small cell lung cancer . Eur J Cardio-Thorac Surg 1995 ; 9 : 59 – 64 . 13 Shepherd FA Evans WK Feld R . Adjuvant

Full access

Andrea Angelo Martoni, Luigi Cavanna, and Gianpiero Porzio

Medicina non Convenzionale della Regione Emilia-Romagna.”) The primary objective was improvement of CRF, assessed as score reduction in the Brief Fatigue Inventory (BFI). 3 To be eligible, patients with no evidence of disease after adjuvant chemotherapy

Full access

Sherif R. Z. Abdel-Misih, Lai Wei, Al B. Benson III, Steven Cohen, Lily Lai, John Skibber, Neal Wilkinson, Martin Weiser, Deborah Schrag, and Tanios Bekaii-Saab

chemotherapy after preoperative therapy for rectal cancer. 23 This study concluded that adjuvant chemotherapy demonstrated no statistically significant improvement in disease-free survival or OS in patients after neoadjuvant treatment. This naturally prompts

Full access

Mary F. Mulcahy, Andrew O. Wahl, and William Small Jr.

III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer . J Clin Oncol 2005 ; 23 ( suppl ): 1092S . 5 Tepper J Nardi G Sutt H . Carcinoma of the pancreas: review of MGH experience